Drug Shortage Report for TEVETEN

Last updated on 2020-07-31 History
Report ID 97447
Drug Identification Number 02243942
Brand name TEVETEN
Common or Proper name Eprosartan mesylate
Company Name BGP PHARMA ULC
Market Status MARKETED
Active Ingredient(s) EPROSARTAN
Strength(s) 600MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 28 CA
ATC code C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2019-11-15
Actual start date 2019-11-19
Estimated end date 2020-07-28
Actual end date 2020-07-28
Shortage status Resolved
Updated date 2020-07-31
Company comments
Health Canada comments
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v19 2020-07-31 French Compare
v18 2020-07-31 English Compare
v17 2020-07-23 French Compare
v16 2020-07-23 English Compare
v15 2020-07-21 French Compare
v14 2020-07-21 English Compare
v13 2020-07-14 French Compare
v12 2020-07-14 English Compare
v11 2019-12-11 French Compare
v10 2019-12-11 English Compare
v9 2019-12-11 French Compare
v8 2019-12-11 English Compare
v7 2019-11-20 French Compare
v6 2019-11-20 English Compare
v5 2019-11-16 English Compare
v4 2019-11-12 French Compare
v3 2019-11-12 English Compare
v2 2019-10-29 French Compare
v1 2019-10-29 English Compare